265 related articles for article (PubMed ID: 20883548)
1. Immune reconstitution following rabbit antithymocyte globulin.
Gurkan S; Luan Y; Dhillon N; Allam SR; Montague T; Bromberg JS; Ames S; Lerner S; Ebcioglu Z; Nair V; Dinavahi R; Sehgal V; Heeger P; Schroppel B; Murphy B
Am J Transplant; 2010 Sep; 10(9):2132-2141. PubMed ID: 20883548
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of homeostatic proliferation and thymopoiesis after rATG induction therapy in kidney transplant patients.
Bouvy AP; Kho MM; Klepper M; Litjens NH; Betjes MG; Weimar W; Baan CC
Transplantation; 2013 Nov; 96(10):904-13. PubMed ID: 23985721
[TBL] [Abstract][Full Text] [Related]
3. Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation.
Valdez-Ortiz R; Bestard O; Llaudó I; Franquesa M; Cerezo G; Torras J; Herrero-Fresneda I; Correa-Rotter R; Grinyó JM
Transpl Int; 2015 Jan; 28(1):108-19. PubMed ID: 25208307
[TBL] [Abstract][Full Text] [Related]
4. Low-dose rabbit antithymocyte globulin induction therapy results in prolonged selective lymphocyte depletion irrespective of maintenance immunosuppression.
Pankewycz O; Leca N; Kohli R; Wallace PK; Said M; Feng L; Alnimri M; Patel S; Laftavi MR
Transplant Proc; 2011 Mar; 43(2):462-5. PubMed ID: 21440734
[TBL] [Abstract][Full Text] [Related]
5. The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins.
Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; Mol W; Weimar W; Baan CC
Clin Exp Immunol; 2010 Aug; 161(2):364-77. PubMed ID: 20528886
[TBL] [Abstract][Full Text] [Related]
6. T cells Exhibit Reduced Signal Transducer and Activator of Transcription 5 Phosphorylation and Upregulated Coinhibitory Molecule Expression After Kidney Transplantation.
Bouvy AP; Klepper M; Kho MM; Ijzermans JN; Betjes MG; Weimar W; Baan CC
Transplantation; 2015 Sep; 99(9):1995-2003. PubMed ID: 25769075
[TBL] [Abstract][Full Text] [Related]
7. Induction of bona fide regulatory T cells after liver transplantation - the potential influence of polyclonal antithymocyte globulin.
Stauch D; Yahyazadeh A; Bova R; Melloh GC; Füldner A; Baron U; Olek S; Göldner K; Weiss S; Pratschke J; Kotsch K
Transpl Int; 2012 Mar; 25(3):302-13. PubMed ID: 22188119
[TBL] [Abstract][Full Text] [Related]
8. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.
Sewgobind VD; Kho MM; van der Laan LJ; Hendrikx TK; van Dam T; Tilanus HW; IJzermans JN; Weimar W; Baan CC
Nephrol Dial Transplant; 2009 May; 24(5):1635-44. PubMed ID: 19176684
[TBL] [Abstract][Full Text] [Related]
9. ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells.
Broady R; Yu J; Levings MK
Blood; 2009 Dec; 114(24):5003-6. PubMed ID: 19822903
[TBL] [Abstract][Full Text] [Related]
10. T-cell receptor sequencing reveals selected donor-reactive CD8
Ningoo M; Cruz-Encarnación P; Khilnani C; Heeger PS; Fribourg M
Am J Transplant; 2024 May; 24(5):755-764. PubMed ID: 38141722
[TBL] [Abstract][Full Text] [Related]
11. The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients.
Bouvy AP; Klepper M; Kho MM; Boer K; Betjes MG; Weimar W; Baan CC
Nephrol Dial Transplant; 2014 Aug; 29(8):1587-97. PubMed ID: 24771499
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of T-Cell Subsets Following Thymoglobulin-Induced Depletion in High Immunologic Risk and Donation After Cardiac Death Renal Transplant Recipients.
Akbari M; Saha MN; Telfer S; Ullah S; Mok A; McAlister V; Juriasingani S; Luke PP; Sener A
Transplant Proc; 2019; 51(6):1744-1753. PubMed ID: 31399162
[TBL] [Abstract][Full Text] [Related]
13. Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine.
Morelon E; Lefrançois N; Besson C; Prévautel J; Brunet M; Touraine JL; Badet L; Touraine-Moulin F; Thaunat O; Malcus C
Transpl Immunol; 2010 May; 23(1-2):53-8. PubMed ID: 20406686
[TBL] [Abstract][Full Text] [Related]
14. Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.
Haller MJ; Gitelman SE; Gottlieb PA; Michels AW; Perry DJ; Schultz AR; Hulme MA; Shuster JJ; Zou B; Wasserfall CH; Posgai AL; Mathews CE; Brusko TM; Atkinson MA; Schatz DA
Diabetes; 2016 Dec; 65(12):3765-3775. PubMed ID: 27669730
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trial.
Büchler M; Longuet H; Lemoine R; Herr F; Gatault P; Thibault G; Ternant D; Foulon C; Pilorge B; Lemay D; Sung C; Halimi JM; Baron C; Lebranchu Y
Transpl Immunol; 2013 Mar; 28(2-3):120-6. PubMed ID: 23507258
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
[TBL] [Abstract][Full Text] [Related]
17. Rapid T cell repopulation after rabbit anti-thymocyte globulin (rATG) treatment is driven mainly by cytomegalovirus.
Havenith SH; Remmerswaal EB; Bemelman FJ; Yong SL; van Donselaar-van der Pant KA; van Lier RA; Ten Berge IJ
Clin Exp Immunol; 2012 Sep; 169(3):292-301. PubMed ID: 22861369
[TBL] [Abstract][Full Text] [Related]
18. Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes.
Ashokkumar C; Sun Q; Ningappa M; Higgs BW; Mazariegos G; Zeevi A; Sindhi R
Transplantation; 2015 Jan; 99(1):164-70. PubMed ID: 25531894
[TBL] [Abstract][Full Text] [Related]
19. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro.
Feng X; Kajigaya S; Solomou EE; Keyvanfar K; Xu X; Raghavachari N; Munson PJ; Herndon TM; Chen J; Young NS
Blood; 2008 Apr; 111(7):3675-83. PubMed ID: 18250226
[TBL] [Abstract][Full Text] [Related]
20. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.
Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; van Dam T; Ijzermans JN; Weimar W; Baan CC
Transplantation; 2010 Mar; 89(6):655-66. PubMed ID: 20164820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
